Type 2 diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects whose oral temperature can be measured; 2. Subjects over 18 years old; 3. Subjects with type 2 diabetes (see Appendix) were diagnosed according to WHO1999 criteria. 4. The subjects who agreed to participate in the clinical study and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients who refused to collect venous blood during the trial; 2. Patients with fever (axillary temperature >= 37.3 degrees C) or symptoms of vomiting, diarrhea (defecation frequency >= 4 times / day), syncope and dehydration were screened; 3. Patients in pregnancy or lactation period; 4. Patients with intravenous infusion planned during the trial period; 5. Patients who plan to adjust hypoglycemic treatment during the trial; 6. Patients with mental illness, lack of self-control or unable to express their wishes clearly; 7. Patients considered unsuitable by the researchers; 8. Patients who participated in other clinical trials in the past month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accuracy of noninvasive glucose measurement;Product ease-of-use evaluation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Accuracy of invasive glucose measurement; | — |
Countries
China